
Puma Biotech has pounced to secure FDA approval for its extended adjuvant treatment for early-stage, HER2-positive breast cancer. The drug, …

Puma Biotechnology breast cancer drug that could be used to reduce the risk of disease recurrence has been boosted by …
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
Phoenix Labs acquires Kent Pharma
Astoriom acquires Sampled’s UK stability storage operations

